Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
Filed with SSE ·
6ix hasn’t read this filing yet.
Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix
Earlier from Zhejiang Shouxiangu Pharmaceutical
- Indicative Announcement on "Shouxiangu 22 Convertible Bond" Expected to Meet Conditions for Revising Conversion Price Downward
- Announcement on Progress of Using Partial Temporary Idle Raised Funds for Cash Management
- Announcement on the Results of Optional Sell-back of "Shouxiangu 22 Convertible Bonds"
- The 3rd Indicative Announcement on the Put Option of "Shouxiangu 22 Convertible Bonds."
- The 2nd Indicative Announcement on the Put Option of "Shouxiangu 22 Convertible Bonds"
Later from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Using Partial Idle Raised Funds for Cash Management and Early Redemption
- Announcement on Completion of Filing of Domestic Health Food by Wholly-owned Subsidiary
- 2024 Annual Preliminary Earnings Estimate
- Report for Q1 2025
- Announcement on Holding Investor Reception Day 2025
Follow Zhejiang Shouxiangu Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shouxiangu Pharmaceutical